Wave Life Sciences (WVE) Operating Margin (2016 - 2025)
Wave Life Sciences' Operating Margin history spans 11 years, with the latest figure at 606.49% for Q2 2025.
- For Q2 2025, Operating Margin fell 42877.0% year-over-year to 606.49%; the TTM value through Dec 2025 reached 1205.01%, down 115736.0%, while the annual FY2025 figure was 504.09%, 40215.0% down from the prior year.
- Operating Margin reached 606.49% in Q2 2025 per WVE's latest filing, down from 542.82% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 11.51% in Q4 2024 to a low of 13648.77% in Q3 2022.
- Average Operating Margin over 5 years is 1910.08%, with a median of 205.98% recorded in 2023.
- Peak YoY movement for Operating Margin: plummeted -1362789bps in 2022, then soared 1365780bps in 2023.
- A 5-year view of Operating Margin shows it stood at 46.35% in 2021, then decreased by -16bps to 53.65% in 2022, then soared by 73bps to 14.57% in 2023, then surged by 179bps to 11.51% in 2024, then tumbled by -5368bps to 606.49% in 2025.
- Per Business Quant, the three most recent readings for WVE's Operating Margin are 606.49% (Q2 2025), 542.82% (Q1 2025), and 11.51% (Q4 2024).